ICE Bioscience, a leading integrated drug discovery contract research organization (CRO) founded in 2010, is thrilled to announce its participation as an exhibitor at the upcoming 2025 BioPacific Conference, hosted by the Chinese-American Bio/Pharmaceutical Society (CABS). The event will take place on Saturday, September 13, 2025, from 8:00 AM to 6:00 PM PDT at the South San Francisco Conference Center, 255 South Airport Boulevard, South San Francisco, CA 94080.

Under the theme "Frontiers in Healthcare: Forging Global Impact Through Science, Innovation, and Partnership", the 26th Annual CABS Conference promises to bring together industry leaders, researchers, and innovators to explore the latest advancements in biotechnology. ICE Bioscience will be showcasing its cutting-edge platforms, including cardiac safety screening, ion channel drug screening, and comprehensive early-stage drug discovery services ranging from target validation to pre-clinical candidate identification.

Attendees are invited to visit the ICE Bioscience booth to learn more about the company’s tailored services and discuss potential partnerships. The event will feature a full day of networking, keynote speeches, and panel discussions, providing an ideal platform for meaningful connections.

ICE Bioscience © 2025